Cargando…

ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer has the highest lethality among gynecological tumors. Therefore, it is essential to find reliable biomarkers to improve early detection. This is the first report describing ADAM17 detection in serum and ascites fluid of ovarian cancer patients. A high ADAM17 concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogmans, Christoph, Kuhlmann, Jan Dominik, Hugendieck, Gerrit, Link, Theresa, Arnold, Norbert, Weimer, Jörg Paul, Flörkemeier, Inken, Rambow, Anna-Christina, Lieb, Wolfgang, Maass, Nicolai, Bauerschlag, Dirk O., Hedemann, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583642/ https://www.ncbi.nlm.nih.gov/pubmed/34771725 http://dx.doi.org/10.3390/cancers13215563

Ejemplares similares

Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer
por: Hugendieck, Gerrit, et al.
Publicado: (2023)

ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
por: Hedemann, Nina, et al.
Publicado: (2021)

Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
por: Rogmans, Christoph, et al.
Publicado: (2022)

ADAM17 inhibition enhances platinum efficiency in ovarian cancer
por: Hedemann, Nina, et al.
Publicado: (2018)

High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)

Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2022)

Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab
por: Weimer, Jörg, et al.
Publicado: (2023)

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)

Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors
por: Oberg, Hans‐Heinrich, et al.
Publicado: (2019)

Phosphatidylserine exposure is required for ADAM17 sheddase function
por: Sommer, Anselm, et al.
Publicado: (2016)

Tetraspanin 8 Subfamily Members Regulate Substrate-Specificity of a Disintegrin and Metalloprotease 17
por: Müller, Miryam, et al.
Publicado: (2022)

Control of ADAM17 activity by regulation of its cellular localisation
por: Lorenzen, Inken, et al.
Publicado: (2016)

Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy
por: Vasku, Marketa, et al.
Publicado: (2011)

Erratum: Control of ADAM17 activity by regulation of its cellular localisation
por: Lorenzen, Inken, et al.
Publicado: (2016)

Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer
por: Schubert, Melanie, et al.
Publicado: (2023)

ADAM 17 endopeptidase
Publicado: (2009)

Fertility Preservation in Female Patients with Breast Cancer – a Current Overview
por: Guenther, Veronika, et al.
Publicado: (2017)

The role of ADAM17 in the T-cell response against bacterial pathogens
por: Link, Moritz Andreas, et al.
Publicado: (2017)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
por: Del Turco, Domenico, et al.
Publicado: (2014)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

The enhanced susceptibility of ADAM-17 hypomorphic mice to DSS-induced colitis is not ameliorated by loss of RIPK3, revealing an unexpected function of ADAM-17 in necroptosis
por: Fuchslocher Chico, Johaiber, et al.
Publicado: (2018)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells
por: Ebsen, Henriette, et al.
Publicado: (2013)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer
por: Sikora-Skrabaka, Magdalena, et al.
Publicado: (2022)

ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023)

Exploring the Potential Role of ADAM 17 and ADAM 22 in the Etiology of Autism Spectrum Disorders
por: Al-Mazidi, Sarah H., et al.
Publicado: (2023)

Epidermal ADAM17 is dispensable for Notch activation
por: Groot, Arjan J., et al.
Publicado: (2013)

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2020)

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2019)

Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells
por: Siney, Elodie J., et al.
Publicado: (2016)

Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
por: Alabi, Rolake O., et al.
Publicado: (2021)

Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
por: Kılıc, Sevilay, et al.
Publicado: (2022)

ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non-redundantly to ADAM17
por: Zatovicova, Miriam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_an60coa6njq7ola51rl5n8b657